JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1998) 156, 59-65       DOI: 10.1677/joe.0.1560059
© 1998 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (62)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hibberts, N.
Right arrow Articles by Randall, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hibberts, N.
Right arrow Articles by Randall, V.
Journal of Endocrinology, Vol 156, Issue 1, 59-65
Copyright © 1998 by Society for Endocrinology


Articles

Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp

NA Hibberts, AE Howell, and VA Randall


Androgens can gradually transform large scalp hair follicles to smaller vellus ones, causing balding. The mechanisms involved are unclear, although androgens are believed to act on the epithelial hair follicle via the mesenchyme-derived dermal papilla. This study investigates whether the levels and type of androgen receptors in primary lines of cultured dermal papilla cells derived from balding scalp hair follicles differ from those of follicles from non-balding scalp. Androgen receptor content was measured by saturation analysis using the non-metabolisable androgen, [3H]mibolerone (0.05-10 nM) in a 9-10 point assay. Pubic dermal fibroblasts and Shionogi cells were examined as positive controls. Repetitive assays of Shionogi cells showed good precision in the levels of androgen receptor content (coefficient of variation = 3.7%). Specific, high affinity, low capacity androgen receptors were detected in dermal papilla cells from both balding and non-balding follicles. Balding cells contained significantly (P < 0.01) greater levels of androgen receptors (Bmax = 0.06 +/- 0.01 fmol/10(4) cells (mean +/- S.E.M.)) than those from non-balding scalp (0.04 +/- 0.001). Competition studies with a range of steroids showed no differences in receptor binding specificity in the two cell types. The higher levels of androgen receptors in cells from balding scalp hair follicles with similar properties to those from non-balding scalp concur with the expectations from their in vivo responses to androgens. This supports the hypothesis that androgens act via the dermal papilla and suggests that cultured dermal papilla cells may offer a model system for studying androgen action in androgenetic alopecia.


This article has been cited by other articles:


Home page
J EndocrinolHome page
V. A Randall, T. J Jenner, N. A Hibberts, I. O De Oliveira, and T. Vafaee
Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles
J. Endocrinol., April 1, 2008; 197(1): 11 - 23.
[Abstract] [Full Text] [PDF]


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
M. Wald, M. Miner, and A. D. Seftel
State of the Art Reviews: Male Menopause: Fact or Fiction?
American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 132 - 141.
[Abstract] [PDF]


Home page
JEMHome page
I. Cima, N. Corazza, B. Dick, A. Fuhrer, S. Herren, S. Jakob, E. Ayuni, C. Mueller, and T. Brunner
Intestinal Epithelial Cells Synthesize Glucocorticoids and Regulate T Cell Activation
J. Exp. Med., December 20, 2004; 200(12): 1635 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. G. Giles, G. Severi, R. Sinclair, D. R. English, M. R. E. McCredie, W. Johnson, P. Boyle, and J. L. Hopper
Androgenetic Alopecia and Prostate Cancer: Findings from an Australian Case-Control Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 549 - 553.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Demark-Wahnefried, J. M. Schildkraut, E. Hawk, B. I. Graubard, and R. A. Breslow
Correspondence re: E. Hawk, et al., Male Pattern Baldness and Clinical Prostate Cancer in the Epidemiologic Follow-Up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 415 - 416.
[Full Text]


Home page
Endocr. Rev.Home page
D. Deplewski and R. L. Rosenfield
Role of Hormones in Pilosebaceous Unit Development
Endocr. Rev., August 1, 2000; 21(4): 363 - 392.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Demark-Wahnefried, J. M. Schildkraut, D. Thompson, S. M. Lesko, L. McIntyre, P. Schwingl, D. F. Paulson, C. N. Robertson, E. E. Anderson, and P. J. Walther
Early Onset Baldness and Prostate Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 325 - 328.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
P. A. Lotufo, C. U. Chae, U. A. Ajani, C. H. Hennekens, and J. E. Manson
Male Pattern Baldness and Coronary Heart Disease: The Physicians' Health Study
Arch Intern Med, January 24, 2000; 160(2): 165 - 171.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald
Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect
Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905.
[Full Text] [PDF]


Home page
NEJMHome page
R. Paus and G. Cotsarelis
The Biology of Hair Follicles
N. Engl. J. Med., August 12, 1999; 341(7): 491 - 497.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for Endocrinology.